首页> 外文期刊>Tetrahedron letters: The International Journal for the Rapid Publication of Preliminary Communications in Organic Chemistry >Synthesis of 5-(3,4-dichlorophenyl)-4-[(methyloxy)methyl]-2-azabicyclo [3.2.1]octane derivatives as constrained aryl-piperidines with activity as triple re-uptake inhibitors
【24h】

Synthesis of 5-(3,4-dichlorophenyl)-4-[(methyloxy)methyl]-2-azabicyclo [3.2.1]octane derivatives as constrained aryl-piperidines with activity as triple re-uptake inhibitors

机译:5-(3,4-二氯苯基)-4-[(甲氧基)甲基] -2-氮杂双环[3.2.1]辛烷衍生物的合成,作为受约束的芳基-哌啶,具有三重再摄取抑制剂的活性

获取原文
获取原文并翻译 | 示例
           

摘要

Stereochemical and synthetic aspects encountered during the preparation of the four possible isomers of 1 are reported. The 5-aryl 2-azabicyclo [3.2.1 ] octane derivatives represent a novel class of compounds which can be deemed as an example of aryl-piperidine conformationally constrained of potential interest for medicinal chemistry exploration. In particular isomers of 1 are characterised by a potent in vitro serotonine, dopamine and noradrenaline re-uptake inhibitor (TRU1) activity superior/comparable to standard compounds such as DOV 21,947 and DOV 102,677.
机译:据报道在制备1的四种可能的异构体过程中遇到的立体化学和合成方面。 5-芳基2-氮杂双环[3.2.1]辛烷衍生物代表一类新型化合物,可以视作芳基-哌啶构象的一个实例,对药用化学探索具有潜在的兴趣。特别是1的异构体,其特征是在体外具有强大的5-羟色胺,多巴胺和去甲肾上腺素再摄取抑制剂(TRU1)活性,优于/可与标准化合物(例如DOV 21,947和DOV 102,677)相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号